FDA — authorised 30 January 2012
- Application: NDA203388
- Marketing authorisation holder: GENENTECH
- Local brand name: ERIVEDGE
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 Erivedge in United States
FDA authorised Erivedge on 30 January 2012
Marketing authorisation
Erivedge in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Erivedge approved in United States?
Yes. FDA authorised it on 30 January 2012.
Who is the marketing authorisation holder for Erivedge in United States?
GENENTECH holds the US marketing authorisation.